EquitiesBrief
Lawmakers question oversight of clinical trial prediction markets
Earnings
Sens. Angela Alsobrooks and Ron Wyden are seeking information from the Department of Health and Human Services regarding risks associated with prediction markets tied to clinical trials and drug approvals. The senators are investigating how these platforms operate and what regulatory steps the agency has taken to mitigate potential risks. These markets allow participants to bet on the outcomes of medical research and regulatory decisions. Monitor for any formal response or policy guidance from the Department of Health and Human Services regarding the oversight of these prediction platforms.
Source: CNBC Markets
Read full story →